ArticleMedical sciences (Basel, Switzerland)2025
Rheumatoid Arthritis Prevalence and Risk Factors in Korean Adults: A Focus on Age and Sex Differences.
Article in Medical sciences (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Weekly Walking Attenuates the Association Between Frailty and Depressive Symptoms in Patients With Rheumatoid Arthritis.Research in nursing & health · 2026Observational
- The problem with one-size-fits-all medicine: Biological sex and the aging immune system.PLoS biology · 2026Article
- [Commentary on the article "Epidemiological profile of rheumatoid arthritis"].Revista medica del Instituto Mexicano del Seguro Social · 2026Article
- Immune network dysregulation in rheumatoid arthritis and systemic lupus erythematosus: cytokine signatures, autoantibody profiles, and implications for precision medicine.Frontiers in medicine · 2026Article
- How social factors relate to arthritis risk in Chinese older adults: population-based evidence.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affects the joints, causing swelling, pain, stiffness, and functional decline. This study aims to clarify the prevalence and risk factors of RA based on sex and age among Korean adults, providing essential data for targeted prevention and management strategies. We analyzed data from the Korea National Health and Nutrition Examination Survey 2016-2021, comprising 25,166 participants aged 20 and older. Sociodemographics, health status, and behavior factors were evaluated, with RA defined based on self-reported diagnosis. A complex sampling design was utilized to ensure representative results and multiple logistic regression was employed to determine the risk factors linked to RA. The overall prevalence of RA among Korean adults was 1.1%, showing a significant sex-based disparity: 0.6% and 1.7% in men and women, respectively. RA prevalence increased with age, peaking at 3.5% in individuals over 70. This study identified education level, subjective health status, and age as key predictors of RA. Among men, significant predictors of RA included education level and subjective health status, with a higher risk observed in men with only elementary education and poor perceived health. For women, age and subjective health status were the main risk factors, with RA risk increasing markedly in older age groups, particularly in those aged 70 and above. This study highlights the distinct prevalence and risk factors for RA among Korean adults by sex and age. Key predictors-education level, subjective health status, and age-suggest that tailored health interventions addressing these factors are crucial to reducing the RA burden and enhancing health outcomes among affected populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.